David P Hochman's most recent trade in Orchestra BioMed Holdings Inc was a trade of 34,038 Common Stock, par value $0.0001 per share ("Common Stock") done at an average price of $3.1 . Disclosure was reported to the exchange on June 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.14 per share. | 11 Jun 2025 | 34,038 | 545,460 | - | 3.1 | 106,879 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.14 per share. | 11 Jun 2025 | 5,671 | 329,331 | - | 3.1 | 17,807 | Common Stock |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 147,500 | 147,500 | - | - | Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 98,333 | 579,498 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.23 per share. | 07 Mar 2025 | 80,080 | 499,418 | - | 4.2 | 338,738 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | Hochman P. David | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.66 per share. | 23 Dec 2024 | 4,000 | 579,498 | - | 4.7 | 18,640 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | Hochman David P. | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.91 per share. | 18 Dec 2024 | 5,000 | 575,498 | - | 4.9 | 24,550 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.91 per share. | 24 Sep 2024 | 2,500 | 570,498 | - | 4.9 | 12,275 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.73 per share. | 24 Sep 2024 | 2,000 | 2,000 | - | 4.7 | 9,460 | Common Stock |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.70 per share. | 24 Sep 2024 | 2,000 | 2,000 | - | 4.7 | 9,400 | Common Stock |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.74 per share. | 24 Sep 2024 | 2,000 | 2,000 | - | 4.7 | 9,480 | Common Stock |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 24 Sep 2024 | 1,500 | 335,002 | - | 4.9 | 7,290 | Common Stock |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.84 per share. | 14 Aug 2024 | 2,500 | 567,998 | - | 5.8 | 14,600 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.95 per share. | 25 Jun 2024 | 1,000 | 333,502 | - | 7.0 | 6,950 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 5.15 per share. | 16 May 2024 | 3,000 | 332,502 | - | 5.2 | 15,450 | Common Stock |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.15 per share. | 16 May 2024 | 3,000 | 332,502 | - | 5.2 | 15,450 | Common Stock |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 4.75 per share. | 16 May 2024 | 2,000 | 329,502 | - | 4.8 | 9,500 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 16 May 2024 | 2,000 | 329,502 | - | 4.8 | 9,500 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 100,000 | 565,498 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 100,000 | 327,502 | - | 0 | Common Stock | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 300,000 | 465,498 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 165,000 | 227,502 | - | 0 | Common Stock | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 132,000 | 132,000 | - | - | Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 100,500 | 100,500 | - | - | Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 300,181 | 300,181 | - | - | Nonstatutory Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 208,216 | 208,216 | - | - | Nonstatutory Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | David P. Hochman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 116,250 | 116,250 | - | - | Nonstatutory Stock Option (Right to Buy) | |
Motus GI Holdings Inc | David P. Hochman | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 40,000 | 132,114 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
Motus GI Holdings Inc | David P. Hochman | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Motus GI Holdings Inc | David P. Hochman | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 32,472 | 164,586 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
Motus GI Holdings Inc | David P. Hochman | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 15,741 | 92,114 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
Motus GI Holdings Inc | David P. Hochman | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 04 Dec 2020 | 5,000 | 76,373 (0%) | 0% | 1.0 | 4,965 | Common Stock, par value $0.0001 per share |
Motus GI Holdings Inc | David P. Hochman | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2020 | 18,466 | 71,373 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share |